MAIA Biotechnology, Inc.
  • About
    • About Us
    • Management
    • Board of Directors
    • Advisors
    • Careers
  • Programs
    • Pipeline
    • THIO Program
    • Second-Generation Programs
    • Publications
  • Partners
  • Investors
  • Contact
  • Menu Menu
  • Twitter
  • LinkedIn

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Analyst Coverage
    • Presentations
    • Contacts
    • FAQ
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
Aug 17, 2021 4:05pm EDT

MAIA Biotechnology, Inc. Appoints Joseph F. McGuire as Chief Financial Officer and Provides Corporate Update

Aug 04, 2021 4:12pm EDT

MAIA Biotechnology, Inc. Announces Additions to Executive Team and Board of Directors

May 19, 2021 8:00am EDT

MAIA Biotechnology, Inc. Raises $8.0 Million Financing to Advance Pipeline of Targeted Immuno-Oncology Studies

Mar 25, 2021 4:05pm EDT

MAIA Biotechnology to Present at Upcoming Investor Conferences

Feb 02, 2021 8:00am EST

MAIA Biotechnology, Inc. Announces Clinical Supply Agreement with Regeneron for Phase 1/2 Clinical Trial Evaluating THIO in Sequential Administration with Libtayo® (cemiplimab) in Advanced Non-Small Cell Lung Cancer

  • arrow_back
  • 1
  • 2
  • 3
  • 4
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© Copyright 2023 - MAIA Biotechnology, Inc.     312.416.8592     |     info@maiabiotech.com     |     Terms of Use    |     Privacy Policy    |     Cookies Policy